Garry Smith

Person

Royersford, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
EBNA1 inhibitors and their method of use
- Patent number 12,258,314
- Issue date Mar 25, 2025
- The Wistar Institute of Anatomy and Biology
- Troy E. Messick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Riluzole prodrugs and their use
- Patent number 12,213,965
- Issue date Feb 4, 2025
- Biohaven Therapeutics Ltd.
- Jay Edward Wrobel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prodrugs of riluzole and their method of use
- Patent number 12,172,974
- Issue date Dec 24, 2024
- Biohaven Pharmaceutical Holding Company Ltd.
- Garry Robert Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EBNA1 inhibitor crystalline forms, and methods of preparing and usi...
- Patent number 12,116,359
- Issue date Oct 15, 2024
- The Wistar Institute
- Troy E. Messick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Riluzole prodrugs and their use
- Patent number 12,005,047
- Issue date Jun 11, 2024
- Biohaven Therapeutics Ltd.
- Jay Edward Wrobel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Riluzole prodrugs and their use
- Patent number 12,005,046
- Issue date Jun 11, 2024
- Biohaven Therapeutics Ltd.
- Jay Edward Wrobel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EBNA1 inhibitors and methods using same
- Patent number 11,912,659
- Issue date Feb 27, 2024
- The Wistar Institute of Anatomy and Biology
- Troy E. Messick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prodrugs of riluzole and their method of use
- Patent number 11,911,369
- Issue date Feb 27, 2024
- Biohaven Therapeutics Ltd.
- Jay Edward Wrobel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prodrugs of riluzole and their method of use
- Patent number 11,440,893
- Issue date Sep 13, 2022
- Biohaven Pharmaceutical Holding Company Ltd.
- Garry Robert Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EBNA1 inhibitor crystalline forms, and methods of preparing and usi...
- Patent number 11,242,338
- Issue date Feb 8, 2022
- The Wistar Institute
- Troy E. Messick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EBNA1 inhibitors and their method of use
- Patent number 11,242,317
- Issue date Feb 8, 2022
- The Wistar Institute of Anatomy and Biology
- Troy E. Messick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pro-drugs of riluzole and their method of use for the treatment of...
- Patent number 11,197,864
- Issue date Dec 14, 2021
- Biohaven Pharmaceutical Holding Company Limited
- Allen B. Reitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Riluzole prodrugs and their use
- Patent number 11,052,070
- Issue date Jul 6, 2021
- Biohaven Therapeutics Ltd.
- Jay Edward Wrobel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EBNA1 inhibitors and methods using same
- Patent number 10,981,867
- Issue date Apr 20, 2021
- The Wistar Institute of Anatomy and Biology
- Troy E. Messick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted N-acetyl-L-cysteine derivatives and related compounds
- Patent number 10,961,187
- Issue date Mar 30, 2021
- Promentis Pharmaceuticals, Inc.
- Michael Neary
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Riluzole prodrugs and their use
- Patent number 10,905,681
- Issue date Feb 2, 2021
- Biohaven Therapeutics Ltd.
- Jay Edward Wrobel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prodrugs of riluzole and their method of use
- Patent number 10,844,026
- Issue date Nov 24, 2020
- Biohaven Pharmaceutical Holding Company Ltd.
- Garry Robert Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prodrugs of riluzole and their method of use
- Patent number 10,639,298
- Issue date May 5, 2020
- Biohaven Therapeutics Ltd.
- Jay Edward Wrobel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prodrugs of riluzole and their method of use
- Patent number 10,562,870
- Issue date Feb 18, 2020
- Biohaven Pharmaceutical Holding Company Ltd.
- Garry Robert Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Riluzole prodrugs and their use
- Patent number 10,485,791
- Issue date Nov 26, 2019
- Biohaven Therapeutics Ltd.
- Jay Edward Wrobel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EBNA1 inhibitors and methods using same
- Patent number 10,442,763
- Issue date Oct 15, 2019
- The Wistar Institute of Anatomy and Biology
- Troy E. Messick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EBNA1 inhibitors and their method of use
- Patent number 10,421,718
- Issue date Sep 24, 2019
- The Wistar Institute of Anatomy and Biology
- Troy E. Messick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pro-drugs of riluzole and their method of use for the treatment of...
- Patent number 10,357,497
- Issue date Jul 23, 2019
- Biohaven Pharmaceutical Holding Company Limited
- Allen B. Reitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted N-acetyl-L-cysteine derivatives and related compounds
- Patent number 10,358,414
- Issue date Jul 23, 2019
- Promentis Pharmaceuticals, Inc.
- Michael Neary
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EBNA1 inhibitors and their method of use
- Patent number 9,856,214
- Issue date Jan 2, 2018
- The Wistar Institute of Anatomy and Biology
- Troy E. Messick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prodrugs of riluzole and their method of use
- Patent number 9,725,427
- Issue date Aug 8, 2017
- Biohaven Pharmaceutical Holding Company Limited
- Garry R. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted N-acetyl-L-cysteine derivatives and related compounds
- Patent number 9,630,937
- Issue date Apr 25, 2017
- Promentis Pharmaceuticals, Inc.
- Michael Neary
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Propionic acids, propionic acid esters, and related compounds
- Patent number 9,193,681
- Issue date Nov 24, 2015
- Promentis Pharmaceuticals, Inc.
- Michael Neary
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic azaindoles
- Patent number 8,853,391
- Issue date Oct 7, 2014
- Merck Patent GmbH
- Bayard R. Huck
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxylated sulfamides exhibiting neuroprotective action and their...
- Patent number 8,609,849
- Issue date Dec 17, 2013
- Fox Chase Chemical Diversity Center, Inc.
- Garry Robert Smith
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
EBNA1 Inhibitors and Methods Using Same
- Publication number 20240246909
- Publication date Jul 25, 2024
- The Wistar Institute of Anatomy and Biology
- Troy E. Messick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
- Publication number 20240091205
- Publication date Mar 21, 2024
- BIOHAVEN THERAPEUTICS LTD.
- Jay Edward Wrobel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED N-ACETYL-L-CYSTEINE DERIVATIVES AND RELATED COMPOUNDS
- Publication number 20240059649
- Publication date Feb 22, 2024
- PROMENTIS PHARMACEUTICALS, INC.
- Michael Neary
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RILUZOLE PRODRUGS AND THEIR USE
- Publication number 20230381149
- Publication date Nov 30, 2023
- BIOHAVEN THERAPEUTICS LTD.
- Jay Edward Wrobel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RILUZOLE PRODRUGS AND THEIR USE
- Publication number 20230381150
- Publication date Nov 30, 2023
- BIOHAVEN THERAPEUTICS LTD.
- Jay Edward Wrobel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
- Publication number 20230202993
- Publication date Jun 29, 2023
- Biohaven Pharmaceutical Holding Company Ltd.
- Garry Robert Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EBNA1 Inhibitor Crystalline Forms, and Methods of Preparing and Usi...
- Publication number 20230103362
- Publication date Apr 6, 2023
- The Wistar Institute
- TROY E. MESSICK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RILUZOLE PRODRUGS AND THEIR USE
- Publication number 20230017637
- Publication date Jan 19, 2023
- BIOHAVEN THERAPEUTICS LTD.
- Jay Edward Wrobel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EBNA1 Inhibitors and Their Method of Use
- Publication number 20220396551
- Publication date Dec 15, 2022
- The Wistar Institute of Anatomy and Biology
- Troy E. Messick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
- Publication number 20220396555
- Publication date Dec 15, 2022
- BIOHAVEN THERAPEUTICS LTD.
- Jay Edward Wrobel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC LATE...
- Publication number 20220388962
- Publication date Dec 8, 2022
- BIOHAVEN THERAPEUTICS LTD.
- Marianne CARLSEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PRO-DRUGS OF RILUZOLE AND THEIR METHOD OF USE FOR THE TREATMENT OF...
- Publication number 20220072006
- Publication date Mar 10, 2022
- Biohaven Pharmaceutical Holding Company Limited (B
- Allen B. Reitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EBNA1 Inhibitors and Methods Using Same
- Publication number 20220064112
- Publication date Mar 3, 2022
- The Wistar Institute of Anatomy and Biology
- Troy E. Messick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED N-ACETYL-L-CYSTEINE DERIVATIVES AND RELATED COMPOUNDS
- Publication number 20210395194
- Publication date Dec 23, 2021
- PROMENTIS PHARMACEUTICALS, INC.
- Michael Neary
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
- Publication number 20210236470
- Publication date Aug 5, 2021
- BIOHAVEN THERAPEUTICS LTD.
- Jay Edward Wrobel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RILUZOLE PRODRUGS AND THEIR USE
- Publication number 20210236471
- Publication date Aug 5, 2021
- BIOHAVEN THERAPEUTICS LTD.
- Jay Edward Wrobel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RILUZOLE PRODRUGS AND THEIR USE
- Publication number 20210228549
- Publication date Jul 29, 2021
- BIOHAVEN THERAPEUTICS LTD.
- Jay Edward Wrobel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
- Publication number 20210078962
- Publication date Mar 18, 2021
- Biohaven Pharmaceutical Holding Company Ltd.
- Garry Robert Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RILUZOLE PRODRUGS AND THEIR USE
- Publication number 20200289475
- Publication date Sep 17, 2020
- BIOHAVEN THERAPEUTICS LTD.
- Jay Edward Wrobel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EBNA1 INHIBITORS AND METHODS USING SAME
- Publication number 20200239415
- Publication date Jul 30, 2020
- The Wistar Institute of Anatomy and Biology
- Troy E. Messick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EBNA1 INHIBITORS AND THEIR METHOD OF USE
- Publication number 20200181078
- Publication date Jun 11, 2020
- The Wistar Institute of Anatomy and Biology
- Troy E. Messick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
- Publication number 20200157069
- Publication date May 21, 2020
- Biohaven Pharmaceutical Holding Company Ltd.
- Garry Robert Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RILUZOLE PRODRUGS AND THEIR USE
- Publication number 20200085794
- Publication date Mar 19, 2020
- Biohaven Therapeutics Ltd.
- Jay Edward Wrobel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRO-DRUGS OF RILUZOLE AND THEIR METHOD OF USE FOR THE TREATMENT OF...
- Publication number 20200000818
- Publication date Jan 2, 2020
- Biohaven Pharmaceutical Holding Company Limited (B
- Allen B. Reitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EBNA1 Inhibitor Crystalline Forms, and Methods of Preparing and Usi...
- Publication number 20190352285
- Publication date Nov 21, 2019
- The Wistar Institute
- TROY E. MESSICK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED N-ACETYL-L-CYSTEINE DERIVATIVES AND RELATED COMPOUNDS
- Publication number 20190315683
- Publication date Oct 17, 2019
- PROMENTIS PHARMACEUTICALS, INC.
- Michael Neary
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EBNA1 INHIBITORS AND METHODS USING SAME
- Publication number 20180305312
- Publication date Oct 25, 2018
- The Wistar Institute of Anatomy and Biology
- Troy E. Messick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EBNA1 INHIBITORS AND THEIR METHOD OF USE
- Publication number 20180086699
- Publication date Mar 29, 2018
- The Wistar Institute of Anatomy and Biology
- TROY E. MESSICK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
- Publication number 20170334870
- Publication date Nov 23, 2017
- Biohaven Pharmaceutical Holding Company Ltd.
- Garry Robert Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED N-ACETYL-L-CYSTEINE DERIVATIVES AND RELATED COMPOUNDS
- Publication number 20170210716
- Publication date Jul 27, 2017
- PROMENTIS PHARMACEUTICALS, INC.
- Michael Neary
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Garry Smith

Person

Patents Grantslast 30 patents

EBNA1 inhibitors and their method of use

Riluzole prodrugs and their use

Prodrugs of riluzole and their method of use

EBNA1 inhibitor crystalline forms, and methods of preparing and usi...

Riluzole prodrugs and their use

Riluzole prodrugs and their use

EBNA1 inhibitors and methods using same

Prodrugs of riluzole and their method of use

Prodrugs of riluzole and their method of use

EBNA1 inhibitor crystalline forms, and methods of preparing and usi...

EBNA1 inhibitors and their method of use

Pro-drugs of riluzole and their method of use for the treatment of...

Riluzole prodrugs and their use

EBNA1 inhibitors and methods using same

Substituted N-acetyl-L-cysteine derivatives and related compounds

Riluzole prodrugs and their use

Prodrugs of riluzole and their method of use

Prodrugs of riluzole and their method of use

Prodrugs of riluzole and their method of use

Riluzole prodrugs and their use

EBNA1 inhibitors and methods using same

EBNA1 inhibitors and their method of use

Pro-drugs of riluzole and their method of use for the treatment of...

Substituted N-acetyl-L-cysteine derivatives and related compounds

EBNA1 inhibitors and their method of use

Prodrugs of riluzole and their method of use

Substituted N-acetyl-L-cysteine derivatives and related compounds

Propionic acids, propionic acid esters, and related compounds

Tricyclic azaindoles

Hydroxylated sulfamides exhibiting neuroprotective action and their...

Patents Applicationslast 30 patents

EBNA1 Inhibitors and Methods Using Same

PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE

SUBSTITUTED N-ACETYL-L-CYSTEINE DERIVATIVES AND RELATED COMPOUNDS

RILUZOLE PRODRUGS AND THEIR USE

RILUZOLE PRODRUGS AND THEIR USE

PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE

EBNA1 Inhibitor Crystalline Forms, and Methods of Preparing and Usi...

RILUZOLE PRODRUGS AND THEIR USE

EBNA1 Inhibitors and Their Method of Use

PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE

MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC LATE...

PRO-DRUGS OF RILUZOLE AND THEIR METHOD OF USE FOR THE TREATMENT OF...

EBNA1 Inhibitors and Methods Using Same

SUBSTITUTED N-ACETYL-L-CYSTEINE DERIVATIVES AND RELATED COMPOUNDS

PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE

RILUZOLE PRODRUGS AND THEIR USE

RILUZOLE PRODRUGS AND THEIR USE

PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE

RILUZOLE PRODRUGS AND THEIR USE

EBNA1 INHIBITORS AND METHODS USING SAME

EBNA1 INHIBITORS AND THEIR METHOD OF USE

PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE

RILUZOLE PRODRUGS AND THEIR USE

PRO-DRUGS OF RILUZOLE AND THEIR METHOD OF USE FOR THE TREATMENT OF...

EBNA1 Inhibitor Crystalline Forms, and Methods of Preparing and Usi...

SUBSTITUTED N-ACETYL-L-CYSTEINE DERIVATIVES AND RELATED COMPOUNDS

EBNA1 INHIBITORS AND METHODS USING SAME

EBNA1 INHIBITORS AND THEIR METHOD OF USE

PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE

SUBSTITUTED N-ACETYL-L-CYSTEINE DERIVATIVES AND RELATED COMPOUNDS